Aurobindo plans second U.S. plant as Trump calls for local production | Reuters

By Zeba Siddiqui | MUMBAI MUMBAI Indian drugmaker Aurobindo Pharma plans to set up a factory in the United States for injectable products, it said on Friday, days after U.S. President Donald Trump called on pharmaceutical companies to make more drugs locally.Trump urged U.S. drug industry executives at a meeting last month to increase local manufacturing and to bring down medicine prices

Reuters February 10, 2017 20:36:26 IST
Aurobindo plans second U.S. plant as Trump calls for local production
| Reuters

Aurobindo plans second US plant as Trump calls for local production
 Reuters

By Zeba Siddiqui
| MUMBAI

MUMBAI Indian drugmaker Aurobindo Pharma plans to set up a factory in the United States for injectable products, it said on Friday, days after U.S. President Donald Trump called on pharmaceutical companies to make more drugs locally.Trump urged U.S. drug industry executives at a meeting last month to increase local manufacturing and to bring down medicine prices. He has also proposed to impose a penalty in the form of a "border tax" on U.S. imports, a move criticised by several import-dependant industries.His comments have worried some in India's roughly $15 billion pharmaceutical industry which supplies about 30 percent of the medicines sold in the United States and relies on the country for the bulk of its export revenue."With the current landscape of what's happening with the U.S. White House administration, and some of the things that may change there, clearly, we don't think having capacity in the U.S. would be detrimental at this point," Aurobindo's U.S. chief, Bob Cunard, told an earnings briefing.Aurobindo, India's fourth biggest drugmaker by sales, makes more than half its revenue in the United States selling everything from HIV/AIDS medicines to anti-bacterials to schizophrenia drugs. It makes tablets in New Jersey but much of its U.S. supply still comes from its six factories in India.

Cunard said the company was planning to put the injectable drugs factory at its New Jersey site.Aurobindo also reported lower than expected profit in the final quarter of 2016 on Friday as it was hurt by price erosion in the United States.

BORDER TAX
Trump is also looking to repeal the Affordable Care Act, a move that would leave some Americans without insurance and make them more reliant on cheap generics, said D.G. Shah, secretary general of the Indian Pharmaceutical Association that represents 20 large generic drugmakers.While not all Indian drug makers are looking to boost their U.S. manufacturing presence just yet, most are watching closely for any policy changes.

"We are extremely vigilant," said Nilesh Gupta, managing director of India's third biggest drugmaker Lupin, which made its biggest U.S. investment in 2015 through a $880 million deal to buy generic drug assets there. In an interview on Thursday, Gupta said Lupin had no plans to scale up its U.S. manufacturing but cautioned: "If there is ever a border tax or something, then obviously, we will need to revisit the whole situation." Lupin's CEO, Vinita Gupta, said the cost of such a tax would have to be passed on to patients and the U.S. healthcare system, meaning this would go against Trump's goal to lower drug prices.Rival Cipla, which made a $550 million acquisition in the United states last year in its biggest boost to business there, said it did not plan on changing its strategy just yet. "We will watch the evolving regulatory aspects in the U.S., but it's unlikely that generics will get impacted," said Kedar Upadhye, Cipla's chief financial officer. (Editing by Euan Rocha and David Clarke)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.